Literature DB >> 17971680

Elimination of organic anions in response to an early stage of renal ischemia-reperfusion in the rat: role of basolateral plasma membrane transporters and cortical renal blood flow.

Gisela Di Giusto1, Naohiko Anzai, Hitoshi Endou, Adriana M Torres.   

Abstract

BACKGROUND/AIMS: The knowledge of molecular mechanisms determining drug pharmacokinetics in pathological states is relevant for the development of new therapeutic approaches. This study was undertaken to evaluate the cortical renal blood flow (cRBF) and the renal protein expression of the organic anion transporters (OAT1 and OAT3) in association with the elimination of organic anions in an early stage of renal ischemia-reperfusion.
METHODS: Ischemic acute renal failure (ARF) was induced in adult male Wistar rats by occlusion of both renal pedicles during 60 min, followed by 60 min of reperfusion (ARF group). Pair-fed sham-operated rats served as controls. The renal protein expression of OAT1 and OAT3 was evaluated by immunohistochemistry techniques and by Western blotting in renal cortex homogenates and in basolateral plasma membranes. A pharmacokinetic study of p-aminohippurate (PAH, a prototypical organic anion) was performed. cRBF was determined using fluorescent microspheres.
RESULTS: ARF rats displayed a significant decrease in systemic clearance and in renal excretion of PAH. OAT1 and OAT3 protein abundance showed a statistically significant reduction both in homogenates and in basolateral plasma membranes from ARF rats. Immunohistochemical studies confirmed the changes in the cortical renal expression of these transporters. ARF animals also showed a decrease in cRBF.
CONCLUSIONS: The decrease in PAH elimination observed in an early stage of renal ischemia-reperfusion in male Wistar rats might be explained by the sum of the lower OAT1 and OAT3 expression in renal basolateral plasma membranes plus the decrease in cRBF. These findings might have significant implications in the development of novel pharmacological strategies to be applied in the initial stages of ischemic ARF. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17971680     DOI: 10.1159/000110555

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  15 in total

1.  Renal elimination of organic anions in cholestasis.

Authors:  Adriana Monica Torres
Journal:  World J Gastroenterol       Date:  2008-11-21       Impact factor: 5.742

Review 2.  The SLC22 Transporter Family: A Paradigm for the Impact of Drug Transporters on Metabolic Pathways, Signaling, and Disease.

Authors:  Sanjay K Nigam
Journal:  Annu Rev Pharmacol Toxicol       Date:  2018-01-06       Impact factor: 13.820

3.  The urinary excretion of an organic anion transporter as an early biomarker of methotrexate-induced kidney injury.

Authors:  María J Severin; Mara S Trebucobich; Patricia Buszniez; Anabel Brandoni; Adriana M Torres
Journal:  Toxicol Res (Camb)       Date:  2016-01-07       Impact factor: 3.524

4.  Gut-derived uremic toxin handling in vivo requires OAT-mediated tubular secretion in chronic kidney disease.

Authors:  Kevin T Bush; Prabhleen Singh; Sanjay K Nigam
Journal:  JCI Insight       Date:  2020-04-09

5.  Deletion of multispecific organic anion transporter Oat1/Slc22a6 protects against mercury-induced kidney injury.

Authors:  Adriana M Torres; Ankur V Dnyanmote; Kevin T Bush; Wei Wu; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

6.  In vivo renal arginine release is impaired throughout development of chronic kidney disease.

Authors:  Gin-Fu Chen; Chris Baylis
Journal:  Am J Physiol Renal Physiol       Date:  2009-11-11

Review 7.  Toward a systems level understanding of organic anion and other multispecific drug transporters: a remote sensing and signaling hypothesis.

Authors:  Sun-Young Ahn; Sanjay K Nigam
Journal:  Mol Pharmacol       Date:  2009-06-10       Impact factor: 4.436

8.  Oat5 and NaDC1 protein abundance in kidney and urine after renal ischemic reperfusion injury.

Authors:  Gisela Di Giusto; Naohiko Anzai; Hitoshi Endou; Adriana M Torres
Journal:  J Histochem Cytochem       Date:  2008-09-15       Impact factor: 2.479

9.  Multispecific drug transporter Slc22a8 (Oat3) regulates multiple metabolic and signaling pathways.

Authors:  Wei Wu; Neema Jamshidi; Satish A Eraly; Henry C Liu; Kevin T Bush; Bernhard O Palsson; Sanjay K Nigam
Journal:  Drug Metab Dispos       Date:  2013-08-06       Impact factor: 3.922

10.  Effects of voluntary wheel running on the kidney at baseline and after ischaemia-reperfusion-induced acute kidney injury: a strain difference comparison.

Authors:  Natasha C Moningka; Mark W Cunningham; Myrline Sterling; Crystal A West; Jill W Verlander; Byron P Croker; Joslyn Ahlgren; Linda Hayward; Chris Baylis
Journal:  J Physiol       Date:  2012-12-24       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.